Application 021866

Type: NDA
Sponsor: OTSUKA

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ABILIFY	ARIPIPRAZOLE	INJECTABLE;INTRAMUSCULAR	9.75MG/1.3ML (7.5MG/ML)	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021866-001	ABILIFY	ARIPIPRAZOLE	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR			2006-09-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021866-001	ABILIFY	9.75MG/1.3ML (7.5MG/ML)	INJECTABLE / INTRAMUSCULAR	2006-09-20	`3a93d1ddd44b…`

Observed Orange Book patent history#

Patent history page 2 of 4 · 150 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Source SHA-256
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021866-001	7115587*PED	2025-01-21		Pediatric extension	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021866-001	7550445*PED	2025-01-21		Pediatric extension	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021866-001	7115587	2024-07-21	U-764	Drug product	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021866-001	7550445	2024-07-21		Drug product	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021866-001	7115587*PED	2025-01-21		Pediatric extension	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021866-001	7550445*PED	2025-01-21		Pediatric extension	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021866-001	7115587	2024-07-21	U-764	Drug product	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021866-001	7550445	2024-07-21		Drug product	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021866-001	7115587*PED	2025-01-21		Pediatric extension	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021866-001	7550445*PED	2025-01-21		Pediatric extension	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021866-001	7115587	2024-07-21	U-764	Drug product	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021866-001	7550445	2024-07-21		Drug product	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021866-001	7115587*PED	2025-01-21		Pediatric extension	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021866-001	7550445*PED	2025-01-21		Pediatric extension	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021866-001	7115587	2024-07-21	U-764	Drug product	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021866-001	7550445	2024-07-21		Drug product	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021866-001	7115587*PED	2025-01-21		Pediatric extension	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021866-001	7550445*PED	2025-01-21		Pediatric extension	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021866-001	7115587	2024-07-21	U-764	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021866-001	7550445	2024-07-21		Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021866-001	7115587*PED	2025-01-21		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021866-001	7550445*PED	2025-01-21		Pediatric extension	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021866-001	7115587	2024-07-21	U-764	Drug product	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021866-001	7550445	2024-07-21		Drug product	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021866-001	7115587*PED	2025-01-21		Pediatric extension	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021866-001	7550445*PED	2025-01-21		Pediatric extension	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021866-001	7115587	2024-07-21	U-764	Drug product	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021866-001	7550445	2024-07-21		Drug product	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021866-001	7115587*PED	2025-01-21		Pediatric extension	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021866-001	7550445*PED	2025-01-21		Pediatric extension	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021866-001	7115587	2024-07-21	U-764	Drug product	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021866-001	7550445	2024-07-21		Drug product	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021866-001	7115587*PED	2025-01-21		Pediatric extension	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021866-001	7550445*PED	2025-01-21		Pediatric extension	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021866-001	7115587	2024-07-21	U-764	Drug product	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021866-001	7550445	2024-07-21		Drug product	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021866-001	7115587*PED	2025-01-21		Pediatric extension	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021866-001	7550445*PED	2025-01-21		Pediatric extension	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021866-001	7115587	2024-07-21	U-764	Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021866-001	7550445	2024-07-21		Drug product	`8869cabd3fbd…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021866-001	ODE-80	2021-12-12	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	N021866-001	ODE-80	2021-12-12	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021866-001	ODE-80	2021-12-12	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021866-001	ODE-80	2021-12-12	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021866-001	ODE-80	2021-12-12	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021866-001	ODE-80	2021-12-12	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021866-001	ODE-80	2021-12-12	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021866-001	ODE-80	2021-12-12	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021866-001	ODE-80	2021-12-12	`ea99ee380514…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 6 · 113 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Aripiprazole	ARIPIPRAZOLE	REMEDYREPACK INC.	b72c0cff-9f4d-42e2-b884-d06dea3e6378	2026-09-08	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
aripiprazole	ARIPIPRAZOLE	Apotex Corp.	14910dae-da81-3d73-d0a4-e98d13917c69	2026-09-03	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	REMEDYREPACK INC.	1d593ada-256d-4dec-9a26-2a6a67d97205	2026-07-31	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	REMEDYREPACK INC.	bc3fde41-2f24-44e2-815d-15fe55bd68b3	2026-07-30	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	REMEDYREPACK INC.	506fa28f-6f98-4632-bce8-72a9cb507c90	2026-07-29	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	REMEDYREPACK INC.	f713c38e-cc49-4243-96b9-32d5dbbcf9cb	2026-07-29	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
aripiprazole	ARIPIPRAZOLE	REMEDYREPACK INC.	1ad7d167-1235-4c5c-8159-da8972240ede	2026-07-27	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Aurobindo Pharma Limited	7bf7d35e-46a1-4e8f-aeb5-8a93223a4abc	2026-07-23	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	REMEDYREPACK INC.	119e3387-39a2-4fe5-904b-c2d008425c0a	2026-07-22	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	REMEDYREPACK INC.	99747897-22fe-4bee-9942-6349c0c8f6b0	2026-07-17	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Aurobindo Pharma Limited	476b92f3-cf7b-4c09-ac67-6ed35e6811d5	2026-07-15	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Coupler LLC	56439ef6-a07e-34c9-e063-6294a90a77c3	2026-07-10	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Coupler LLC	55f3a705-9412-0f88-e063-6294a90a2b53	2026-07-06	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Coupler LLC	55f446b0-caa2-aca8-e063-6294a90af441	2026-07-06	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	REMEDYREPACK INC.	a1191a90-eb83-4a59-948c-b9774d2c83a5	2026-07-02	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Bryant Ranch Prepack	69af5199-f872-4298-8d09-035e2127d3d4	2026-06-29	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Unit Dose Solutions, Inc.	535f4fbd-b6a7-7611-e063-6294a90a5c43	2026-06-03	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Coupler LLC	52cc86ba-2c4f-1aba-e063-6294a90a844e	2026-05-27	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Coupler LLC	52bbfc8f-fa17-839e-e063-6394a90a6316	2026-05-26	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Bryant Ranch Prepack	c092a736-16e2-4dd0-8769-cb766a62f4d9	2026-05-13	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 3 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
59148-016	ABILIFY	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-016	ABILIFY	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-016	ABILIFY	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
61831	SUPPL	2020-02-06
61830	SUPPL	2020-02-06
61829	SUPPL	2020-02-06
61828	SUPPL	2020-02-06
61801	SUPPL	2020-02-06
61800	SUPPL	2020-02-06
59640	SUPPL	2019-08-08
59639	SUPPL	2019-08-08
59625	SUPPL	2019-08-08
47427	SUPPL	2017-03-02
47327	SUPPL	2017-02-24
45052	SUPPL	2016-08-23
45053	SUPPL	2016-08-18
37792	SUPPL	2016-01-22
6342	SUPPL	2016-01-20
16485	SUPPL	2014-12-15
6341	SUPPL	2014-12-15
6339	SUPPL	2014-07-11
37790	SUPPL	2014-06-10
37791	SUPPL	2013-08-09
6340	SUPPL	2013-08-05
28743	SUPPL	2012-02-27
37789	SUPPL	2012-02-24
42333	SUPPL	2012-01-27
42332	SUPPL	2012-01-27
21847	SUPPL	2012-01-27
44158	ORIG	2011-12-22
28742	SUPPL	2011-03-08
37788	SUPPL	2011-03-07
37786	SUPPL	2011-02-24
6337	SUPPL	2011-02-18
28741	SUPPL	2010-12-07
16484	SUPPL	2010-12-03
6338	SUPPL	2010-12-03
37787	SUPPL	2010-12-02
28740	SUPPL	2010-02-17
28733	SUPPL	2010-02-14
16481	SUPPL	2010-02-14
28739	SUPPL	2009-07-24
37785	SUPPL	2009-07-23
37784	SUPPL	2008-08-26
28738	SUPPL	2008-08-19
24222	ORIG	2008-08-12
21846	ORIG	2008-08-11
44655	SUPPL	2008-07-17
44654	SUPPL	2008-07-17
44653	SUPPL	2008-07-17
28736	SUPPL	2008-05-14
28735	SUPPL	2008-05-14
6335	SUPPL	2008-05-14
28737	SUPPL	2008-03-07
6336	SUPPL	2008-02-29
16483	SUPPL	2008-02-28
37783	SUPPL	2007-11-19
28734	SUPPL	2007-11-19
6334	SUPPL	2007-11-08
16482	SUPPL	2007-11-07
28732	SUPPL	2007-10-04
16480	SUPPL	2007-09-26
6333	ORIG	2006-09-25
37782	ORIG	2006-09-21
51608	SUPPL	1900-01-01